Reports Q3 revenue $572.94M, consensus $552.14M. “I’m pleased with our ability to continue executing across all areas of our business,” said Danny Prosky, CEO. “Organic growth continues to exceed historical levels, and across our operating portfolio, comprised of our ISHC and SHOP segments, we have benefited from strong secular demand tailwinds in the long-term care sector, highlighted by spot Same-Store SHOP occupancy currently being above 90%. On the capital allocation front, we continue to see favorable transaction activity, which we anticipate will allow us to add to the over $575M of new acquisitions we’ve closed year-to-date in 2025.”
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on AHR:
- American Healthcare REIT price target raised to $51 from $49 at BofA
- American Healthcare REIT price target raised to $50 from $45 at Citizens JMP
- American Healthcare REIT price target raised to $43 from $40 at KeyBanc
- American Healthcare REIT initiated with a Buy at UBS
- Buy Rating for American Healthcare REIT, Inc. Driven by Strong AFFO Growth and Strategic Expansion in Senior Housing